Is This Incredible Dividend Stock Still a Buy Following Its Recent Split?
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Jonhson & Johnson (NYSE: JNJ) has treated its investors like royalty over the years. The healthcare behemoth has increased its dividend payment for 61 straight years. That’s put it in the elite group of Dividend Kings, companies with 50 consecutive years of consistent dividen
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1803777103-b9626d35c9fd4424ae7ecc3b6d58a558.jpg "Accountant Career Path and Qualifications")
:max_bytes(150000):strip_icc():format(jpeg)/AFFLUENT.MILLENNIAL.HERO.GettyImages-868506558_2600-84706e45802340b1865d4b49c285a662.jpg "The Affluent Millennial Investing Survey")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2151279555-f38549a64433496982ff93944b309afb.jpg "5 Transamerica Mutual Funds to Consider")
